CSIMarket Company Name, Ticker, Customers, else..
 
Longview Acquisition Corp Ii  (NYSE: LGV)
Other Ticker:  
 
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 69
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 21
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Longview Acquisition Corp Ii
Longview Acquisition Corp II is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It was incorporated in 2020 and is based in Dallas, Texas. The company is sponsored by Longview Capital Investment, a private investment firm. Longview Acquisition Corp II raised a significant amount of capital through its initial public offering (IPO) for the purpose of acquiring a target company. The specific target industry or company has not been identified yet. The management team of Longview Acquisition Corp II consists of experienced professionals with a track record in mergers, acquisitions, and business operations. The company's objective is to acquire a business that can generate sustainable long-term value for its shareholders.


   Company Address: 767 Fifth Avenue New York 10153 NY
   Company Phone Number: 812-4700   Stock Exchange / Ticker: NYSE LGV


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals Inc disclosed substantial leap in revenue, amid the most recent fiscal period

Concentrating on the fourth quarter of 2025 Sonoma Pharmaceuticals Inc s' loss per share has expanded to $-0.63 from $0.00 year on year, regardless of Revenue growth of 9.16 % to $3.75 million. SNOAs' resists theMedical Equipment and Supplies sectors momentum and expresses top-line surge , as almost all of the Medical Equipment and Supplies sector peers, saw revenue demise over the same period.

Odyssey Health Inc

The Medical Equipment and Supplies company created some good scenario for the stock market, displaying an important growth in February to April 30 2025 with operating shortfall of $-0.129055 million

The shareholders have not assumed some adjustments at the business during the the February to April 30 2025 reporting cycle at the ODYY. However, they pay near attention to the company's operating shortfall that has been at $-0.129055 million, in the same period.

Trisalus Life Sciences Inc

Failed to turn into profitability in spite of surge in revenue, at the Trisalus Life Sciences Inc all along the financial time-frame ending March 31 2025

The Medical Equipment and Supplies company lost money at $-0.39 per share in the financial time-frame ending March 31 2025, although its revenue surged by 34.304 % to $8.67 million from the comparable quarter a year ago. TLSIs' results comes for many as a new revelation, while the Medical Equipment and Supplies company's presents revenue improvement while remainder of Medical Equipment and Supplies industries has -3.26% demise in business.

Inspire Medical Systems Inc

Again Positive Income at INSP amid the January to March 31 2025 interval

Due to bewildering revenue rise INSP turned into profitability, Revenue grew by 22.882 % to $200.61 million, earnings per share were at $0.10, relative to $-0.34 in the corresponding time-frame a previous year.

Catheter Precision Inc

The company declared the loss has been diminished exceptionally, in the first quarter of 2025

Respectable Revenue elevation in its first quarter of 2025 financial report, by 74.39 % to $0.14 million fueled to cut losses to $-0.36 per share, from $-3.60 in same financial reporting period a year prior. Medical Equipment and Supplies company's resists theMedical Equipment and Supplies sectors trend and posts top-line improvement , as virtually all of the Medical Equipment and Supplies industry peers, have recorded revenue reduction during the matching period.










Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com